ONL Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$132.5M

Investors

26 investors across all rounds

Bios Partners

Biosciences Research and Commercialization Center

Capital Community Angels Investors

ExSight Ventures

Hestia Investments

+21 more investors

Explore More Data

Detailed analysis for ONL Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

ONL Therapeutics Leadership & Investors

ONL Therapeutics is led by a team of experienced leaders. The company has attracted investment from 26 institutional and strategic investors.

Who Has Invested in ONL Therapeutics?

ONL Therapeutics has raised $132.5M from 26 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access ONL Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.